KR20040031361A - Cell-activating and toxicity-eliminating agent - Google Patents

Cell-activating and toxicity-eliminating agent Download PDF

Info

Publication number
KR20040031361A
KR20040031361A KR1020020060772A KR20020060772A KR20040031361A KR 20040031361 A KR20040031361 A KR 20040031361A KR 1020020060772 A KR1020020060772 A KR 1020020060772A KR 20020060772 A KR20020060772 A KR 20020060772A KR 20040031361 A KR20040031361 A KR 20040031361A
Authority
KR
South Korea
Prior art keywords
weight
oxide
toxicity
cell
activating
Prior art date
Application number
KR1020020060772A
Other languages
Korean (ko)
Inventor
김고정
김용훈
김용준
Original Assignee
김고정
김용훈
김용준
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김고정, 김용훈, 김용준 filed Critical 김고정
Priority to KR1020020060772A priority Critical patent/KR20040031361A/en
Publication of KR20040031361A publication Critical patent/KR20040031361A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

PURPOSE: Provided is a cell-activating and toxicity-eliminating agent which inhibits cell aging, as well as has antibacterial effect on harmful bacteria and detoxification effect. Therefore, it prevents and treats various kinds of diseases when administered into an animal, and promotes plant growth as well as increases immunity when administered into a plant. CONSTITUTION: A cell-activating and toxicity-eliminating agent is characterized by mixing 75.8 wt.% of SiO2, 1.31 wt.% of Fe2O3, 0.01 wt.% of TiO2, 12.4 wt.% of Al2O3, 2.68 wt.% of CaO, 0.12 wt.% of MgO, 4.08 wt.% of K2O, 3.36 wt.% of Na2O, 0.01 wt.% of MnO and 0.23 wt.% of Ge; and 50-60 wt.% of mixture with 40-50 wt.% of water.

Description

세포활성 및 독성제거제 {cell-activating and toxicity-eliminating agent}Cell-activating and toxicity-eliminating agent

본 발명은 동식물의 세포가 노화되는 진행속도를 억제하고, 유해한 균에 대해 항균력을 가지며, 각종 독성을 제거할 수 있는 세포활성 및 독성제거제에 관한 것이다.The present invention relates to a cell activity and detoxifying agent that inhibits the rate of progress of aging animals and plants, has antibacterial activity against harmful bacteria, and can remove various toxicities.

지구를 구성하는 물질이나 태양빛 등은 각개가 모든 생명체의 세포에 생체전기를 방출하여 세포를 활성화시켜 건강하게 생명을 이어가게 하고, 세균, 곰팡이, 바이러스 등이 생명체에 침입하는 것을 막아 질병을 퇴치시키며, 또한 손상된 세포를 재생시키는 일도 한다.Matter and sunlight, which make up the earth, each releases bioelectricity to cells of all living things to activate the cells and lead them to healthy life, and prevent bacteria, fungi, viruses, etc. from invading them to combat disease And also regenerate damaged cells.

그러한 생체전기는 핵을 중심으로 하는 전자의 운동과 분자간의 운동으로 생긴 것으로 짐작되며, 이러한 생체전기가 세포를 활성화시켜 생명체가 유지 성장될 수 있도록 영향을 주는 것으로 본다.Such bioelectrics are presumed to be caused by the movement of electrons and intermolecular movements around the nucleus, and these bioelectrics activate the cells and influence the growth of life.

그러나 지구에 존재하는 물질 중에는 생체전기를 과다하게 발산하는 물질과, 미약하게 발산하는 물질이 대다수이며, 생명체에 적합한 정도의 생체전기를 발산하는 물질은 아주 적다.However, among the materials present on the earth, the majority of the materials that emit too much bioelectricity, and the ones that emit weakly, and very few materials that emit enough bioelectricity suitable for life.

생체전기를 과도하게 발산하는 물질은 생물에 치명적인 역할을 하는 일이 있다. 예를 들어 방사선 물질과 같이 과도하게 생체전기를 발산하게 되면 모든 세포는 파괴되는 일이 있으며, 발산하는 생체전기가 작은 물질은 생명체에 주는 영향이 적다.Excessive bioelectricity of substances may play a deadly role in living organisms. For example, excessive bioelectricity, such as radioactive substances, may destroy all cells, and a small bioelectric material that emits little influence on life.

이와같은 생체전기로서는 원적외선이 흔히 알려져 있다. 원적외선은 모든 물체에서 방사되며, 원적외선을 방사하는 물질은 이것이 인체에 접할 경우 인체의 열을 흡수하고, 흡수된 열을 원적외선으로 복사하므로서 세포가 원적외선을 흡수하여 공명의 공진흡수현상으로 세포가 활성화된다고 한다.Far infrared rays are commonly known as such bioelectrics. Far infrared rays are emitted from all objects, and materials that emit far infrared rays absorb the heat of the human body when it comes into contact with the human body and radiate the absorbed heat into the far infrared rays, so that the cells absorb the far infrared rays and activate the cells by resonance resonance absorption of resonance. do.

이러한 원적외선 역시 물질을 구성하는 원자의 전자운동으로 발생되는 생체전기의 일종이다. 이와같이 인체에 원적외선을 방사하므로서 세포를 활성화시키는 기술은 이미 공지된 바 있다.This far infrared ray is also a kind of bioelectric generated by the electron motion of the atoms constituting the material. As such, techniques for activating cells by radiating far infrared rays to the human body have been known.

그러나 종래에 있어서는 원적외선 방사 물질을 획득함에 있어, 이를 자연에 존재하는 물질로 부터 선별 획득하던가, 특정의 물질들을 혼합 소결하여 제조하여 왔다.However, conventionally, in obtaining a far-infrared radiation material, it has been selectively obtained from materials existing in nature, or manufactured by mixing and sintering specific materials.

그러나 자연에 존재하는 원적외선 방사물질을 선별 획득하는 것이 용이하지도 아니하고 또 이러한 물질은 원적외선 방사율이 비교적 적은 결점이 있다. 그리하여 종래에는 일반적으로 특정의 물질을 혼합하고 소결하므로서 원적외선 방사 세라믹을 제조 사용하여 왔던 것이다.However, it is not easy to select and acquire far-infrared radioactive materials present in nature, and these materials have the disadvantage of having a relatively low far-infrared emissivity. Thus, conventionally, far-infrared radiation ceramics have been manufactured and used by mixing and sintering specific materials.

그러나 이와같이 원적외선 방사물질을 소결하여 형성시키면 원적외선 방사물질로 부터 탄산가스 등의 기체와 결정수가 이탈되고 물질 자체의 성질이 변화되는 중대한 결점이 있다.However, when the sintered far-infrared radiation material is formed by sintering, gas and crystal water, such as carbon dioxide gas, are separated from the far-infrared radiation material, and the property of the material itself is changed.

그러나 어떠한 물질로부터 방사되는 생체전기는 원적외선에 한하지 아니하며 그외에도 수도 없이 많은 종류의 생체전기가 발생된다고 한다.However, bioelectrics radiated from any substance are not limited to far infrared rays, and many other types of bioelectrics are generated.

본 발명은 이러한 다수종의 생체전기 중 어떠한 생체전기인지는 이를(삭제)확인할 수 없으나, 원적외선의 일종일 것으로 보이는, 원적외선이 아니라면 미지의 생체전기라고 이해되는 생체전기를 발산하여 세포를 활성화시킴은 물론, 각종 독성을 제거하는 물질을 제공함에 본 발명의 목적이 있다.The present invention can not identify (deleting) any of these bioelectrics, but it seems to be a kind of far-infrared, if it is not far-infrared, bioelectrics that are understood as unknown bioelectrics to activate the cells Of course, it is an object of the present invention to provide a substance that eliminates various toxicities.

본 발명은 산화규소(SiO₂) 75.8중량%, 산화철(Fe₂O₃) 1.31중량%, 산화티타늄(TiO₂) 0.01중량%, 산화알미늄(Al₂O₃) 12.4중량%, 산화칼슘(CaO) 2.68중량%, 산화마그네슘(MgO) 0.12중량%, 산화칼륨(K₂O) 4.08중량%, 산화나트륨(Na₂O) 3.36중량%, 일산화망간(MnO) 0.01중량%, 게르마늄(Ge) 0.23중량%를 혼합한 혼합물 50~60 중량%를 물 40∼50중량%와 혼합한 것이다.The present invention is a silicon oxide (SiO₂) 75.8% by weight, iron oxide (Fe₂O₃) 1.31% by weight, titanium oxide (TiO₂) 0.01% by weight, aluminum oxide (Al₂O₃) 12.4% by weight, calcium oxide (CaO) 2.68% by weight, magnesium oxide ( 50% to 60% by weight of a mixture of 0.12% by weight of MgO), 4.08% by weight of potassium oxide (K₂O), 3.36% by weight of sodium oxide (Na₂O), 0.01% by weight of manganese monoxide (MnO), and 0.23% by weight of germanium (Ge) It is mixed with 40-50 weight% of water.

이와같은 본 발명의 세포활성 및 독성제거제가 발산하는 생체전기는 동물이나 식물의 세포를 활성화시켜 생물체의 건강을 증진시킬 뿐만 아니라, 각종 독성을 중화, 제거 시킨다.Such bioelectricity emitted by the cell activity and detoxifying agent of the present invention activates the cells of animals or plants to enhance the health of living organisms, and neutralizes and removes various toxicity.

즉, 본 발명의 세포활성 및 독성제거제를 인체에 바르면 피부의 세포가 활성화되어 피부가 건강하고 아름다워지고 맑아지는 미용 효과를 가지게 될 뿐만 아니라, 피부에 존재하는 각종 독성물질을 제거하여 건강한 피부를 유지시킬 수 있는 것이다.In other words, applying the cell activation and detoxifying agent of the present invention to the human body will activate the cells of the skin and make the skin healthy, beautiful and clear, as well as remove various toxic substances present in the skin to maintain healthy skin. It can be done.

그리고 본 발명의 세포활성 및 독성제거제를 동물에게 경구 투여하면 내장의 세포가 활성화하고 체내의 독성을 제거하여 내장이 건강하게 되고 각종 질병의 예방 및 치료에 효과가 있으며, 식물에 투여하면 식물의 생장이 촉진되고 면역력도 증가됨을 알 수 있었다.And oral administration of the cell activity and detoxifying agent of the present invention to the animal activates the cells of the intestines and removes the toxicity in the body, the intestines are healthy and effective in the prevention and treatment of various diseases, when administered to plants, the growth of plants This was promoted and increased immunity was found.

이와같이 생체전기를 발산하여 세포를 활성화시키고 독성을 제거하는 상기의 물질을 제조하는 방법을 설명하면 다음과 같다.As described above, a method of preparing the above-mentioned material for activating cells and removing toxicity by releasing bioelectricity is as follows.

산화규소(SiO₂) 75.8중량%, 산화철(Fe₂O₃) 1.31중량%, 산화티타늄(TiO₂) 0.01중량%, 산화알미늄(Al₂O₃) 12.4중량%, 산화칼슘(CaO) 2.68중량%, 산화마그네슘(MgO)0.12중량%, 산화칼륨(K₂O) 4.08중량%, 산화나트륨(Na₂O) 3.36중량%, 일산화망간(MnO) 0.01중량%, 게르마늄(Ge) 0.23중량%를 각 입자의 직경이 10mm 이하가 되게 파쇄하여, 이를 유기산 7∼10%수용액(바람직하게는 수산 7∼10% 수용액)에 침지시키고, 온도 80℃~100℃로 24~200시간 가열처리하면 이온교환, 전자, 분자운동이 활발한활성화 된 혼합물이 생산된다.Silicon oxide (SiO₂) 75.8 wt%, iron oxide (Fe₂O₃) 1.31 wt%, titanium oxide (TiO₂) 0.01 wt%, aluminum oxide (Al₂O₃) 12.4 wt%, calcium oxide (CaO) 2.68 wt%, magnesium oxide (MgO) 0.12 Weigh%, potassium oxide (K₂O) 4.08% by weight, sodium oxide (Na₂O) 3.36% by weight, manganese monoxide (MnO) 0.01% by weight, germanium (Ge) 0.23% by weight to crush the particles to 10mm or less, It was immersed in 7-10% aqueous solution of organic acid (preferably 7-10% aqueous solution) and heated for 24 to 200 hours at a temperature of 80 ℃ ~ 100 ℃ to produce an activated mixture with active ion exchange, electron and molecular motion. do.

이와같이 하여 제조된 혼합물을 약 60℃~80℃의 깨끗한 온수에 20∼24시간 담궜다가 물을 빼는 방법으로 수세하되, 같은방법으로 5회 내지 8회 수세하면 pH6∼7정도되는 제2차 제품이 생산된다.The mixture thus prepared is immersed in clean hot water at about 60 ° C to 80 ° C for 20 to 24 hours, followed by washing with water, followed by washing with water 5 to 8 times in the same manner to produce a secondary product having a pH of 6 to 7 do.

그 다음 물 40~50중량%와 혼합물 50∼60중량%를 혼합하여 볼밀로 72시간∼120시간 정도 분쇄하면 365메쉬에 전량 통과하는 10미크론의 작은 입자의 완제품이 생산된다.Then, 40 to 50% by weight of water and 50 to 60% by weight of the mixture are mixed and ground by a ball mill for 72 to 120 hours to produce a finished product of small particles of 10 microns, which passes through 365 meshes.

볼밀로 분쇄시키는 이유는 분쇄시 압전 현상이 생겨 더욱 더 활성화가 되게하며,수분이 활성화된 미립자의 주위에 흡착되어 양이온(H)와 음이온(OH)으로 변하면서 이온교환 기능도 높아지게 하기 위함이다.The reason for the grinding by the ball mill is that the piezoelectric phenomenon occurs during the grinding, which makes the activation even more, and the moisture is adsorbed around the activated fine particles to change into cations (H) and anions (OH), thereby increasing the ion exchange function.

이와같은 본 발명의 세포 활성제의 제조 방법을 상세히 설명하기 위하여 아래에 그 일 실시예를 기재한다.One embodiment is described below to explain in detail the method for producing the cell activator of the present invention.

[실시예]EXAMPLE

산화규소(SiO₂) 75.8gSilicon Oxide (SiO₂) 75.8g

산화철(Fe₂O₃) 1.31gIron oxide (Fe₂O₃) 1.31 g

산화티타늄(TiO₂) 0.01g0.01g titanium oxide (TiO₂)

산화알미늄(Al₂O₃) 12.4gAluminum Oxide (Al₂O₃) 12.4g

산화칼슘(CaO) 2.68Calcium Oxide (CaO) 2.68

산화마그네슘(MgO) 0.12gMagnesium Oxide (MgO) 0.12g

산화칼륨(K₂O) 4.08gPotassium oxide (K₂O) 4.08 g

산화나트륨(Na₂O) 3.36gSodium oxide (Na₂O) 3.36 g

일산화망간(MnO) 0.01gManganese Monoxide (MnO) 0.01g

게르마늄(Ge) 0.23gGermanium (Ge) 0.23 g

을 혼합한 후, 입자의 직경이 10mm 이하가 되게 파쇄하여, 이를 유기산 7~10%수용액(바람직하게는 수산 7∼10% 수용액)에 침지시키고, 온도 100℃로 190시간 가열처리하여 분말상의 혼합물을 생성하였다.After mixing, the particles were crushed to have a diameter of 10 mm or less, immersed in 7-10% aqueous solution of organic acid (preferably 7-10% aqueous solution), and heated at a temperature of 100 ° C. for 190 hours to mix the powdery mixture. Produced.

이와같이 하여 제조된 혼합물을 70℃의 깨끗한 온수에 24시간 담궜다가 물을 빼는 방법으로 7회 수세하여 제2차 제품을 제조하여 혼합물의 산성도는 pH7이 되도록 하였다.The mixture thus prepared was immersed in clean hot water at 70 ° C. for 24 hours and washed with water seven times by removing water to prepare a second product, so that the acidity of the mixture was pH7.

그 다음 물과 혼합물을 1:1(중량비)로 혼합하고 볼밀로 100시간 정도 분쇄하여 365메쉬에 전량 통과하는 크기의 입자로 된 액상의 완제품을 생산하였다.Then, the water and the mixture was mixed in a 1: 1 (weight ratio) and pulverized with a ball mill for about 100 hours to produce a liquid finished product consisting of particles having a size that passes through 365 mesh.

본 발명의 방법에 의하여 제조된 세포활성 및 독성제거제의 급성독성을 조사하기 위하여 암수 SD 랫트(쥐)에 경구로 단회 투여하여 사망여부, 일반증상, 체중의 변화 및 부검소견을 관찰하였다.In order to investigate the acute toxicity of the cellular activity and detoxifying agents prepared by the method of the present invention, oral single doses were administered to male and female SD rats (rats) to observe death, general symptoms, changes in body weight, and necropsy findings.

본 시험결과 625 ~ 5000mg/kg투여군에서 사망동물은 관찰되지 않았고, 일반 증상에 있어서도 시험물질투여에 의한 이상 증상이 관찰되지 않았으며, 체중의 변화 및 육안적 부검소견에 있어서도 시험물질의 영향이라고 사료되는 증상이 관찰되지 않아 본 시험물질에 의한 독성증상은 없었음을 알수 있었다.As a result of this test, no dead animals were observed in the 625 ~ 5000mg / kg dose group, no abnormal symptoms due to the administration of test substance were observed in the general symptoms, and the effect of the test substance on the change of body weight and macroscopic autopsy findings. No symptoms were observed, indicating no toxic symptoms caused by the test substance.

그리고 위와 같이 급성경구투여에 의한 독성증상이 발견되지 않으므로 LD50값은 5000mg/kg이라고 보여지므로(충북대학교 동물의학연구소 1995. 9. 1. 바이오진 액체의 랫드에 대한 급성경구독성시험), 체중60kg인 사람의 경우 상기 실시예에 의하여 제조된 본 발명의 세포 활성제는 이를 300g까지 경구 투여할 수 있다. 다만 본 발명의 세포활성 및 독성제거제의 바람직한 1일 투여량은 고형량 기준 22.5g으로 본다.As the above toxic symptoms by acute oral administration were not found, the LD50 value was shown to be 5000 mg / kg (Acute Oral Toxicity Test of Biogene Liquid Rats). In the case of human, the cell activator of the present invention prepared by the above example can be administered orally up to 300g. However, the preferred daily dose of the cell activity and detoxicant of the present invention is considered to be 22.5 g based on solids.

상기와 같은 본 발명의 세포활성 및 독성제거제를 피부에 도포하는 방법으로 마사지(Massage)하게 되면 피부의 세포가 활성화되어 노화가 방지되며, 피부의 탄력이 증가되고, 피부가 부드러워짐은 물론, 피부에 잔존하는 각종 독성물질을 제거하는 효과가 있고, 동물에게 경구 투여하면 내장의 세포가 활성화하고 체내의 독성을 제거하여 내장이 건강하게 되고 각종 질병의 예방 및 치료에 효과가 있으며, 식물에 투여하면 식물의 생장촉진과 면역력 증가의 효과가 있는 것이다.Massage by the method of applying the cell activity and detoxifying agent of the present invention as described above to the skin (Massage) to activate the cells of the skin to prevent aging, the elasticity of the skin is increased, the skin is soft, of course, the skin It is effective in removing various toxic substances remaining in the body, and oral administration to animals activates the cells of the intestines and removes the toxicity in the body, which makes the intestines healthy and effective in the prevention and treatment of various diseases. It is effective in promoting plant growth and increasing immunity.

Claims (1)

산화규소(SiO₂) 75.8중량%, 산화철(Fe₂O₃) 1.31중량%, 산화티타늄(TiO₂) 0.01중량%, 산화알미늄(Al₂O₃) 12.4중량%, 산화칼슘(CaO) 2.68중량%, 산화마그네슘(MgO)0.12중량%, 산화칼륨(K₂O) 4.08중량%, 산화나트륨(Na₂O) 3.36중량%, 일산화망간(MnO) 0.01중량%, 게르마늄(Ge) 0.23중량%를 혼합한 혼합물 50~60 중량%를 물 40~50중량%와 혼합함을 특징으로 하는 세포활성 및 독성제거제Silicon oxide (SiO₂) 75.8 wt%, iron oxide (Fe₂O₃) 1.31 wt%, titanium oxide (TiO₂) 0.01 wt%, aluminum oxide (Al₂O₃) 12.4 wt%, calcium oxide (CaO) 2.68 wt%, magnesium oxide (MgO) 0.12 50% to 60% by weight of a mixture of 4% by weight, 4.08% by weight of potassium oxide (K₂O), 3.36% by weight of sodium oxide (Na₂O), 0.01% by weight of manganese monoxide (MnO), and 0.23% by weight of germanium (Ge). Cellular activity and detoxifying agent, characterized in that mixed with 50% by weight
KR1020020060772A 2002-10-04 2002-10-04 Cell-activating and toxicity-eliminating agent KR20040031361A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020020060772A KR20040031361A (en) 2002-10-04 2002-10-04 Cell-activating and toxicity-eliminating agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020020060772A KR20040031361A (en) 2002-10-04 2002-10-04 Cell-activating and toxicity-eliminating agent

Publications (1)

Publication Number Publication Date
KR20040031361A true KR20040031361A (en) 2004-04-13

Family

ID=37331593

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020020060772A KR20040031361A (en) 2002-10-04 2002-10-04 Cell-activating and toxicity-eliminating agent

Country Status (1)

Country Link
KR (1) KR20040031361A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS623707A (en) * 1985-06-27 1987-01-09 皆川 功 Fertilizer scattering apparatus
EP0235417A1 (en) * 1986-01-27 1987-09-09 Charles Allen Jensen Inorganic mineral composition
KR980000433A (en) * 1996-06-29 1998-03-30 강석우 Wash-off pack composition manufacturing method using granite
JPH1087430A (en) * 1996-09-13 1998-04-07 Ohara Shigeko Massage cream

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS623707A (en) * 1985-06-27 1987-01-09 皆川 功 Fertilizer scattering apparatus
EP0235417A1 (en) * 1986-01-27 1987-09-09 Charles Allen Jensen Inorganic mineral composition
KR980000433A (en) * 1996-06-29 1998-03-30 강석우 Wash-off pack composition manufacturing method using granite
JPH1087430A (en) * 1996-09-13 1998-04-07 Ohara Shigeko Massage cream

Similar Documents

Publication Publication Date Title
KR100643047B1 (en) Method of Producting of The Biovital-water using material Radiating Far Infared and Mineral
EP1390083B1 (en) Multi-functional material emitting far-infrared ray in aqueous phase and the use thereof
KR20160112370A (en) Method for producing a fine powder of firing ionized calcium and the Nanosize powder of firing ionized calcium antibacterial additive produced with the production method
KR100309182B1 (en) Magnetized versatile plastic ceramic having activation(active function) and a method of preparing powder thereof
KR20020009249A (en) Manufacturing process and composite of inner and outer building materials
KR101893639B1 (en) Loessal water including mineral elements
CN107789654A (en) Discharge the air freshener of element anion
KR100777064B1 (en) Method of Producting of the facial cream preparing Biovital-water using material Radiating Far 0Infared and Mineral
KR101246849B1 (en) Minerals aqueous solution and its manufacturing method
KR100460526B1 (en) High functional composition having action on minus ion and far infrared ray
KR20040031361A (en) Cell-activating and toxicity-eliminating agent
KR20070042247A (en) Natural mineral composition for granular active carbon and method for manufacturing functional environment-friendly granular active carbon filter member therefrom and its filter member
KR102045616B1 (en) Method of antibacterial soap emitting far infrared rays emitted at room temperature or above room temperature
CN105948608A (en) Ecologically healthy environment-friendly cement
KR20090010342A (en) Composition in the form of a ball to energize human bodily function
KR102420144B1 (en) Composition of clay comprising sulfur and method for producing the same
KR101197600B1 (en) Feed additives comprising silicate mineral and feedstuff comprising the same
KR20120006668A (en) Manufacturing method of a paint comprising natural mineral
KR101502083B1 (en) A hygienic diaper include tea-tree, alum, zeolite and SAP a composition and that of manufacturing method
KR0180615B1 (en) Process for preparing cell activator
KR20010027635A (en) composition of mineral stone paints
KR101295405B1 (en) Manufacturing method of ceramic
KR101394956B1 (en) A sprayable chloroprene adhensive composition and method of constructing wallpaper using the same
KR101164125B1 (en) Tinea pedis and eczema remedy the mineral substance and manufacture method thereof
KR102384297B1 (en) Compositions of disinfectants for covid-19 containing mineral calcium and its manufacturing method

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application